Comparison of the incidence of contrast-induced nephropathy after primary PCI in patients receiving high-dose rosuvastatin and atorvastatin

Comparison of the incidence of contrast-induced nephropathy after primary PCI in patients receiving high-dose rosuvastatin and atorvastatin

Introduction: Contrast-induced nephropathy (CIN) is associated with increased disability and death. Randomized clinical trial studies have shown that short-term treatment with statins prior to cardiac intervention was capable of reducing the incidence of CIN. Therefore, the aim of this study was to...

Full description

Bibliographic Details
Main Authors: Samad Golshani, Parastoo Tavasoli, Ali Asghar Farsavian, Hossein Farsavian, Jamshid Yazdani Charati
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
atorvastatin
contrast-induced nephropathy
myocardial infarction
rosuvastatin
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=5;spage=1957;epage=1962;aulast=Golshani

Internet

http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=5;spage=1957;epage=1962;aulast=Golshani

Similar Items